Concord Wealth Partners boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 3.1% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 1,579 shares of the healthcare conglomerate’s stock after purchasing an additional 48 shares during the period. Concord Wealth Partners’ holdings in UnitedHealth Group were worth $805,000 at the end of the most recent quarter.
Other institutional investors also recently bought and sold shares of the company. Outfitter Financial LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter worth $25,000. Blue Bell Private Wealth Management LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter worth $29,000. Advocacy Wealth Management Services LLC lifted its position in shares of UnitedHealth Group by 75.8% during the 1st quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 25 shares during the last quarter. Cascade Investment Advisors Inc. lifted its position in shares of UnitedHealth Group by 100.0% during the 1st quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 30 shares during the last quarter. Finally, Tortoise Investment Management LLC lifted its position in shares of UnitedHealth Group by 54.8% during the 4th quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 23 shares during the last quarter. Hedge funds and other institutional investors own 87.48% of the company’s stock.
Shares of UnitedHealth Group stock opened at $513.63 on Friday. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.54. The company’s 50-day simple moving average is $492.84 and its 200-day simple moving average is $492.36. UnitedHealth Group Incorporated has a 52-week low of $383.12 and a 52-week high of $553.29. The firm has a market cap of $481.87 billion, a price-to-earnings ratio of 28.11, a price-to-earnings-growth ratio of 1.54 and a beta of 0.83.
UnitedHealth Group (NYSE:UNH – Get Rating) last issued its earnings results on Thursday, April 14th. The healthcare conglomerate reported $5.49 earnings per share for the quarter, topping the consensus estimate of $5.40 by $0.09. The company had revenue of $80.15 billion for the quarter, compared to analyst estimates of $78.77 billion. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. The firm’s revenue for the quarter was up 14.2% compared to the same quarter last year. During the same period in the previous year, the business posted $5.31 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 21.75 EPS for the current year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 28th. Stockholders of record on Monday, June 20th were given a $1.65 dividend. The ex-dividend date of this dividend was Thursday, June 16th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.45. This represents a $6.60 annualized dividend and a dividend yield of 1.28%. UnitedHealth Group’s dividend payout ratio is currently 36.12%.
Several equities research analysts have recently issued reports on the stock. Loop Capital began coverage on shares of UnitedHealth Group in a research report on Thursday, June 16th. They set a “buy” rating and a $575.00 price objective for the company. Cowen boosted their price target on shares of UnitedHealth Group from $512.00 to $596.00 in a research report on Monday, April 18th. Sanford C. Bernstein cut shares of UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 price target for the company. in a research report on Thursday, May 26th. They noted that the move was a valuation call. BMO Capital Markets boosted their price target on shares of UnitedHealth Group from $510.00 to $600.00 and gave the company a “market perform” rating in a research report on Tuesday, April 19th. Finally, Credit Suisse Group boosted their price target on shares of UnitedHealth Group from $564.00 to $595.00 and gave the company an “outperform” rating in a research report on Monday, April 18th. Three equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $555.73.
In other news, Director Frederick William Mcnabb III acquired 89 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, May 26th. The shares were acquired at an average price of $504.32 per share, with a total value of $44,884.48. Following the completion of the purchase, the director now owns 11,259 shares of the company’s stock, valued at approximately $5,678,138.88. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction that occurred on Thursday, May 19th. The shares were sold at an average price of $478.96, for a total transaction of $1,197,400.00. Following the transaction, the director now directly owns 1,215,000 shares in the company, valued at approximately $581,936,400. The disclosure for this sale can be found here. Insiders sold 6,273 shares of company stock worth $3,065,752 over the last quarter. Company insiders own 0.40% of the company’s stock.
UnitedHealth Group Company Profile: (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments. UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic diseases and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Get Rating).
Receive News & Ratings for UnitedHealth Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.